Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYHB2100169	克唑替尼胶囊	crizotinib	Capsule	Chemical Drugs	Supplementary Application	2021-03-02	辉瑞投资有限公司	Pfizer Investment Co Ltd	In Review	2021-03-01	view
JYHB2100168	克唑替尼胶囊	crizotinib	Capsule	Chemical Drugs	Supplementary Application	2021-03-02	辉瑞投资有限公司	Pfizer Investment Co Ltd	In Review	2021-03-01	view
CYHS2100054	克唑替尼胶囊	crizotinib	Capsule	Chemical Drugs(4)	Generic Drug	2021-01-13	江苏万邦生化医药集团有限责任公司	Wanbang Biopharmaceuticals	In Review	2021-01-12	view
CYHS2100053	克唑替尼胶囊	crizotinib	Capsule	Chemical Drugs(4)	Generic Drug	2021-01-13	江苏万邦生化医药集团有限责任公司	Wanbang Biopharmaceuticals	In Review	2021-01-12	view
JYHB2002271	克唑替尼胶囊	crizotinib	Capsule	Chemical Drugs	Supplementary Application	2020-11-11	辉瑞投资有限公司	Pfizer Investment Co Ltd	Filed	2020-12-01	view
JYHB2002270	克唑替尼胶囊	crizotinib	Capsule	Chemical Drugs	Supplementary Application	2020-11-11	辉瑞投资有限公司	Pfizer Investment Co Ltd	Filed	2020-12-01	view
JYHB2000645	克唑替尼胶囊	crizotinib	Capsule	Chemical Drugs	Supplementary Application	2020-06-13	辉瑞投资有限公司	Pfizer Investment Co Ltd	Certificate Issued	2020-10-29	view
JYHB2000646	克唑替尼胶囊	crizotinib	Capsule	Chemical Drugs	Supplementary Application	2020-06-13	辉瑞投资有限公司	Pfizer Investment Co Ltd	Certificate Issued	2020-10-29	view
JYHB2001752	克唑替尼胶囊	crizotinib	Capsule	Chemical Drugs	Supplementary Application	2020-09-11	辉瑞投资有限公司	Pfizer Investment Co Ltd	Filed	2020-09-27	view
JYHB2001751	克唑替尼胶囊	crizotinib	Capsule	Chemical Drugs	Supplementary Application	2020-09-11	辉瑞投资有限公司	Pfizer Investment Co Ltd	Filed	2020-09-27	view
JYHB2000066	克唑替尼胶囊	crizotinib	Capsule	Chemical Drugs	Supplementary Application	2020-02-20	辉瑞投资有限公司	Pfizer Investment Co Ltd	Certificate Issued	2020-04-22	view
JYHB2000067	克唑替尼胶囊	crizotinib	Capsule	Chemical Drugs	Supplementary Application	2020-02-20	辉瑞投资有限公司	Pfizer Investment Co Ltd	Certificate Issued	2020-04-22	view
JYHB2000068	克唑替尼胶囊	crizotinib	Capsule	Chemical Drugs	Supplementary Application	2020-01-19	辉瑞投资有限公司	Pfizer Investment Co Ltd	Filed	2020-02-28	view
JYHB2000069	克唑替尼胶囊	crizotinib	Capsule	Chemical Drugs	Supplementary Application	2020-01-19	辉瑞投资有限公司	Pfizer Investment Co Ltd	Filed	2020-02-28	view
JYHB1900647	克唑替尼胶囊	crizotinib	Capsule	Chemical Drugs	Supplementary Application	2019-06-17	辉瑞制药有限公司	Pfizer Pharmaceuticals Ltd	Certificate Issued	2019-08-22	view
JYHB1900646	克唑替尼胶囊	crizotinib	Capsule	Chemical Drugs	Supplementary Application	2019-06-17	辉瑞制药有限公司	Pfizer Pharmaceuticals Ltd	Certificate Issued	2019-08-22	view
JYHB1800571	克唑替尼胶囊	crizotinib	Capsule	Chemical Drugs	Supplementary Application	2018-05-28	辉瑞制药有限公司	Pfizer Pharmaceuticals Ltd	Certificate Issued	2018-07-16	view
JYHB1800572	克唑替尼胶囊	crizotinib	Capsule	Chemical Drugs	Supplementary Application	2018-05-28	辉瑞制药有限公司	Pfizer Pharmaceuticals Ltd	Certificate Issued	2018-07-16	view
JYHB1800321	克唑替尼胶囊	crizotinib	Capsule	Chemical Drugs	Supplementary Application	2018-03-26	辉瑞制药有限公司	Pfizer Pharmaceuticals Ltd	Certificate Issued	2018-06-07	view
JYHB1800320	克唑替尼胶囊	crizotinib	Capsule	Chemical Drugs	Supplementary Application	2018-03-26	辉瑞制药有限公司	Pfizer Pharmaceuticals Ltd	Certificate Issued	2018-06-07	view